Comparison of the purification of biologically active IL-7 cytokine expressed in Escherichia coli and Pichia pastoris

Namen, 1988, Stimulation of B-cell progenitors by cloned murine interleukin-7, Nature, 333, 571, 10.1038/333571a0 Namen, 1988, B cell precursor growth-promoting activity. Purification and characterization of a growth factor active on lymphocyte precursors, J. Exp. Med., 167, 988, 10.1084/jem.167.3.988 Goodwin, 1989, Human interleukin 7: molecular cloning and growth factor activity on human and murine B-lineage cells, Proc. Natl. Acad. Sci. U.S.A., 86, 302, 10.1073/pnas.86.1.302 Cosenza, 1997, Disulfide bond assignment in human interleukin-7 by matrix-assisted laser desorption/ionization mass spectroscopy and site-directed cysteine to serine mutational analysis, J. Biol. Chem., 272, 32995, 10.1074/jbc.272.52.32995 Cosenza, 2000, Comparative model building of interleukin-7 using interleukin-4 as a template: a structural hypothesis that displays atypical surface chemistry in helix D important for receptor activation, Protein Sci., 9, 916, 10.1110/ps.9.5.916 McElroy, 2009, Structural and biophysical studies of the human IL-7/IL-7Ralpha complex, Structure, 17, 54, 10.1016/j.str.2008.10.019 Mazzucchelli, 2007, Interleukin-7 receptor expression: intelligent design, Nat. Rev. Immunol., 7, 144, 10.1038/nri2023 McElroy, 2012, Structural reorganization of the interleukin-7 signaling complex, Proc. Natl. Acad. Sci. U.S.A., 109, 2503, 10.1073/pnas.1116582109 Foxwell, 1995, Interleukin-7 can induce the activation of Jak 1, Jak 3 and STAT 5 proteins in murine T cells, Eur. J. Immunol., 25, 3041, 10.1002/eji.1830251109 Palmer, 2008, Interleukin-7 receptor signaling network: an integrated systems perspective, Cell. Mol. Immunol., 5, 79, 10.1038/cmi.2008.10 Vandergeeten, 2013, Interleukin-7 promotes HIV persistence during antiretroviral therapy, Blood, 121, 4321, 10.1182/blood-2012-11-465625 Onodera, 2013, Too much of a good thing, Nat. Immunol., 14, 112, 10.1038/ni.2510 Kimura, 2013, IL-7 signaling must be intermittent, not continuous, during CD8(+) T cell homeostasis to promote cell survival instead of cell death, Nat. Immunol., 14, 143, 10.1038/ni.2494 Monti, 2014, Interleukin-7 and type 1 diabetes, Curr. Diab. Rep., 14, 518, 10.1007/s11892-014-0518-9 Heninger, 2012, IL-7 abrogates suppressive activity of human CD4+CD25+FOXP3+ regulatory T cells and allows expansion of alloreactive and autoreactive T cells, J. Immunol., 189, 5649, 10.4049/jimmunol.1201286 Lee, 1988, Recombinant interleukin-7 supports the growth of normal B lymphocyte precursors, Curr. Top. Microbiol. Immunol., 141, 16 Penaranda, 2012, IL-7 receptor blockade reverses autoimmune diabetes by promoting inhibition of effector/memory T cells, Proc. Natl. Acad. Sci. U.S.A., 109, 12668, 10.1073/pnas.1203692109 Walsh, 2010, A biosensor study indicating that entropy, electrostatics, and receptor glycosylation drive the binding interaction between interleukin-7 and its receptor, Biochemistry, 49, 8766, 10.1021/bi101050h Walsh, 2012, Structural insights into the common gamma-chain family of cytokines and receptors from the interleukin-7 pathway, Immunol. Rev., 250, 303, 10.1111/j.1600-065X.2012.01160.x Luo, 2009, Expression, purification, and functional characterization of recombinant human interleukin-7, Protein Expr. Purif., 63, 1, 10.1016/j.pep.2008.08.009 Wickham, 2007, Crystallization and preliminary X-ray diffraction of human interleukin-7 bound to unglycosylated and glycosylated forms of its alpha-receptor, Acta Crystallogr., Sect. F: Struct. Biol. Cryst. Commun., 63, 865, 10.1107/S1744309107042807 Graslund, 2008, Protein production and purification, Nat. Methods, 5, 135, 10.1038/nmeth.f.202 Burgess, 2009, Refolding solubilized inclusion body proteins, Methods Enzymol., 463, 259, 10.1016/S0076-6879(09)63017-2 Cereghino, 2000, Heterologous protein expression in the methylotrophic yeast Pichia pastoris, FEMS Microbiol. Rev., 24, 45, 10.1111/j.1574-6976.2000.tb00532.x Cregg, 2007, Introduction: distinctions between Pichia pastoris and other expression systems, Methods Mol. Biol., 389, 1, 10.1007/978-1-59745-456-8_1 Pietrangeli, 1988, Stromal cell lines which support lymphocyte growth: characterization, sensitivity to radiation and responsiveness to growth factors, Eur. J. Immunol., 18, 863, 10.1002/eji.1830180606 Ishihara, 1991, Stromal-cell and cytokine-dependent lymphocyte clones which span the pre-B- to B-cell transition, Dev. Immunol., 1, 149, 10.1155/1991/79721 van de Loosdrecht, 1994, A tetrazolium-based colorimetric MTT assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia, J. Immunol. Methods, 174, 311, 10.1016/0022-1759(94)90034-5 Hamilton, 2007, Glycosylation engineering in yeast: the advent of fully humanized yeast, Curr. Opin. Biotechnol., 18, 387, 10.1016/j.copbio.2007.09.001 Vervecken, 2007, Modification of the N-glycosylation pathway to produce homogeneous, human-like glycans using GlycoSwitch plasmids, Methods Mol. Biol., 389, 119, 10.1007/978-1-59745-456-8_9 Li, 2014, Expression of recombinant human IL-4 in Pichia pastoris and relationship between its glycosylation and biological activity, Protein Expr. Purif., 96, 1, 10.1016/j.pep.2014.01.005 Maley, 1989, Characterization of glycoproteins and their associated oligosaccharides through the use of endoglycosidases, Anal. Biochem., 180, 195, 10.1016/0003-2697(89)90115-2 Tarentino, 1994, Enzymatic deglycosylation of asparagine-linked glycans: purification, properties, and specificity of oligosaccharide-cleaving enzymes from Flavobacterium meningosepticum, Methods Enzymol., 230, 44, 10.1016/0076-6879(94)30006-2 Ouellette, 2003, Production and purification of refolded recombinant human IL-7 from inclusion bodies, Protein Expr. Purif., 30, 156, 10.1016/S1046-5928(03)00134-7 Hamilton, 2006, Humanization of yeast to produce complex terminally sialylated glycoproteins, Science, 313, 1441, 10.1126/science.1130256 Larkin, 2007, Clustal W and Clustal X version 2.0, Bioinformatics, 23, 2947, 10.1093/bioinformatics/btm404 Jacobs, 2009, N-glycosylation engineering of biopharmaceutical expression systems, Curr. Mol. Med., 9, 774, 10.2174/156652409789105552 Mattern, 1994, Endotoxin and lipid A stimulate proliferation of human T cells in the presence of autologous monocytes, J. Immunol., 153, 2996, 10.4049/jimmunol.153.7.2996 Peavy, 1970, The mitogenic effects of endotoxin and staphylococcal enterotoxin B on mouse spleen cells and human peripheral lymphocytes, J. Immunol., 105, 1453, 10.4049/jimmunol.105.6.1453